Skip to main content

Animations

MJFF Publications

1671 - 1680 of 8620 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2021
  • 2021
  • 2024
  • 2024
  • 2024
  • 2022
  • 2017
  • 2023
  • Summary Details
    OPEN
    Title: Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00409-5
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Multi-modality machine learning predicting Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00288-w
    Citation Count: 107
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00247-x
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Multimodal phenotypic axes of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-020-00144-9
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49402-x
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-48961-3
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Radiomic tractometry reveals tract-specific imaging biomarkers in white matter
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-44591-3
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinations
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-28087-0
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Network connectivity determines cortical thinning in early Parkinson’s disease progression
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-017-02416-0
    Citation Count: 247
  • Summary Details
    OPEN
    Title: The Foundational Data Initiative for Parkinson Disease: Enabling efficient translation from genetic maps to mechanism
    Journal Name: Cell Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xgen.2023.100261
    Citation Count: 36
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.